Table 3 Antithrombotic medication prescription distribution
From: Influence of compliance to antithrombotic agents on perioperative morbidity and mortality
Adherence to guidelines | Justification | Total | ||||||
|---|---|---|---|---|---|---|---|---|
No | Yes | Sclerosis of arterial system and left heart | Venous system and right heart | |||||
N | % | N | % | N | % | |||
Total | 223 | 100.00% | 366 | 100.00% | 356 | 233 | 589 | 100.00% |
No treatment | 0 | 0.00% | 26 | 7.10% | 0 | 26 | 26 | 4.40% |
Acenocoumarol | 18 | 8.10% | 20 | 5.50% | 35 | 3 | 38 | 6.50% |
Acetylsalicylic acid | 150 | 67.30% | 228 | 62.30% | 186 | 192 | 378 | 64.20% |
Acetylsalicylic acid + dipyridamole | 0 | 0.00% | 1 | 0.30% | 0 | 1 | 1 | 0.20% |
Apixaban | 11 | 4.90% | 13 | 3.60% | 24 | 0 | 24 | 4.10% |
Clopidogrel | 11 | 4.90% | 13 | 3.60% | 24 | 0 | 24 | 4.10% |
Dabigatran | 3 | 1.30% | 5 | 1.40% | 8 | 0 | 8 | 1.40% |
Edoxaban | 1 | 0.40% | 3 | 0.80% | 4 | 0 | 4 | 0.70% |
Enoxaparin | 13 | 5.80% | 33 | 9.00% | 36 | 10 | 46 | 7.80% |
Unfractionated heparin | 1 | 0.40% | 3 | 0.80% | 4 | 0 | 4 | 0.70% |
Nadroparin | 1 | 0.40% | 1 | 0.30% | 2 | 0 | 2 | 0.30% |
Rivaroxaban | 8 | 3.60% | 17 | 4.60% | 25 | 0 | 25 | 4.20% |
Tinzaparin | 6 | 2.70% | 3 | 0.80% | 8 | 1 | 9 | 1.50% |